Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
29.65
+1.31 (4.62%)
Mar 9, 2026, 4:00 PM EDT - Market closed
Viridian Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 3,030 | 2,970 | 1,519 | 1,145 | 1,176 | 429 | |
| Market Cap Growth | 135.14% | 95.60% | 32.58% | -2.58% | 173.76% | 568.00% | |
| Enterprise Value | 2,208 | 2,692 | 977 | 989 | 892 | 379 | |
| Last Close Price | 29.65 | 31.12 | 19.17 | 21.78 | 29.21 | 19.77 | |
| PS Ratio | 42.77 | 41.92 | 5028.17 | 3647.53 | 663.46 | 144.94 | |
| PB Ratio | 5.12 | 4.11 | 2.26 | 2.59 | 2.98 | 2.29 | |
| P/TBV Ratio | 5.14 | 5.03 | 3.15 | 4.86 | 4.65 | 7.97 | |
| EV/Sales Ratio | 31.17 | 38.00 | 3236.51 | 3150.76 | 503.65 | 127.79 | |
| Debt / Equity Ratio | 0.07 | 0.07 | 0.03 | 0.05 | 0.01 | 0.00 | |
| Net Debt / Equity Ratio | -1.14 | -1.14 | -1.04 | -1.03 | -1.06 | -1.05 | |
| Net Debt / EBITDA Ratio | 2.27 | 2.27 | 2.33 | 1.79 | 3.13 | 2.47 | |
| Net Debt / FCF Ratio | 2.97 | 2.97 | 2.99 | 2.46 | 4.43 | 3.58 | |
| Asset Turnover | 0.09 | 0.09 | 0 | 0.00 | 0.01 | 0.02 | |
| Quick Ratio | 12.37 | 12.37 | 14.99 | 17.93 | 12.73 | 14.48 | |
| Current Ratio | 12.65 | 12.65 | 15.43 | 18.27 | 12.93 | 14.68 | |
| Return on Equity (ROE) | -49.16% | -49.16% | -48.48% | -56.80% | -44.57% | -51.61% | |
| Return on Assets (ROA) | -27.67% | -27.67% | -30.32% | -34.37% | -26.28% | -29.75% | |
| Return on Capital Employed (ROCE) | -43.90% | -43.90% | -43.10% | -54.90% | -33.40% | -41.90% | |
| Earnings Yield | -9.30% | -11.54% | -17.78% | -20.76% | -11.05% | -18.49% | |
| FCF Yield | -9.14% | -9.32% | -15.33% | -16.16% | -8.05% | -12.79% | |
| Buyback Yield / Dilution | -24.92% | -24.92% | -51.68% | -39.48% | -169.22% | -235.07% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.